Cargando…

Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines

Tissue-resident macrophages play critical roles in controlling homeostasis, tissue repair, and immunity. Inflammatory macrophages can sustain tissue damage and promote the development of fibrosis during infections and sterile tissue injury. The NLRP3 inflammasome and its effector cytokine IL-1β have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Köse-Vogel, Nilay, Stengel, Sven, Gardey, Elena, Kirchberger-Tolstik, Tatiana, Reuken, Philipp A., Stallmach, Andreas, Bruns, Tony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016608/ https://www.ncbi.nlm.nih.gov/pubmed/31905600 http://dx.doi.org/10.3390/cells9010079

Ejemplares similares

Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation
por: Ibidapo-obe, Oluwatomi, et al.
Publicado: (2020)

Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis
por: Horn, Paul, et al.
Publicado: (2018)

Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality
por: Reißing, Johanna, et al.
Publicado: (2021)

Development and validation of a simple and robust model to predict 30-day mortality in patients with Clostridioides difficile-associated enterocolitis
por: Katzer, Katrin Claudia, et al.
Publicado: (2020)

Between fear and courage: Attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic
por: Reuken, Philipp A., et al.
Publicado: (2020)

Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study
por: Franz, Anika, et al.
Publicado: (2023)

Compliant Substrates Enhance Macrophage Cytokine Release and NLRP3 Inflammasome Formation During Their Pro-Inflammatory Response
por: Escolano, Joan-Carles, et al.
Publicado: (2021)

Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
por: Reuken, Philipp A., et al.
Publicado: (2017)

Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
por: Reuken, Philipp A., et al.
Publicado: (2017)

Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis
por: Reuken, Philipp A., et al.
Publicado: (2022)

Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series
por: Stallmach, Andreas, et al.
Publicado: (2020)

Folgen nach SARS-CoV-2-Infektion einschließlich Post-COVID-Syndrom
por: Quickert, Stefanie, et al.
Publicado: (2023)

The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2011)

Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells
por: Hillegass, Jedd M, et al.
Publicado: (2013)

ATP release and purinergic signaling in NLRP3 inflammasome activation
por: Gombault, Aurélie, et al.
Publicado: (2013)

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2013)

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2013)

Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages
por: Luheshi, Nadia M, et al.
Publicado: (2012)

Genetic variants of TRAF6 modulate peritoneal immunity and the risk of spontaneous bacterial peritonitis in cirrhosis: A combined prospective-retrospective study
por: Mai, Martina, et al.
Publicado: (2017)

Miltefosine increases macrophage cholesterol release and inhibits NLRP3-inflammasome assembly and IL-1β release
por: Iacano, Amanda J., et al.
Publicado: (2019)

The Role of NLRP3 Inflammasome in Pneumococcal Infections
por: Surabhi, Surabhi, et al.
Publicado: (2020)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release
por: Junqueira, Caroline, et al.
Publicado: (2021)

TSPO Ligands PK11195 and Midazolam Reduce NLRP3 Inflammasome Activation and Proinflammatory Cytokine Release in BV-2 Cells
por: Feng, Hao, et al.
Publicado: (2020)

NLRP3 licenses NLRP11 for inflammasome activation in human macrophages
por: Gangopadhyay, Anu, et al.
Publicado: (2022)

Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages
por: Amaral, Eduardo P., et al.
Publicado: (2018)

NLRP3 inflammasome activation is involved in manganese-induced immunotoxicity: Mn activates macrophage NLRP3 inflammasome
por: Ji, Jing, et al.
Publicado: (2021)

The Role of Cytokines Produced via the NLRP3 Inflammasome in Mouse Macrophages Stimulated with Dental Calculus in Osteoclastogenesis
por: Mae, Megumi, et al.
Publicado: (2021)

Targeting Spike Glycoprotein S1 Mediated by NLRP3 Inflammasome Machinery and the Cytokine Releases in A549 Lung Epithelial Cells by Nanocurcumin
por: Chittasupho, Chuda, et al.
Publicado: (2023)

NLRP3 inflammasome triggers interleukin‐37 release from human monocytes
por: Gritsenko, Anna, et al.
Publicado: (2022)

Clinical characteristics and outcome of patients with enterococcal liver abscess
por: Große, K., et al.
Publicado: (2021)

Pneumolysin Activates the NLRP3 Inflammasome and Promotes Proinflammatory Cytokines Independently of TLR4
por: McNeela, Edel A., et al.
Publicado: (2010)

NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer
por: Faria, Sara Socorro, et al.
Publicado: (2021)

Targeting the NLRP3 inflammasome and associated cytokines in scleroderma associated interstitial lung disease
por: Woo, Samuel, et al.
Publicado: (2023)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

The impact of specific cytokine directed treatment on severe COVID-19
por: Reuken, P. A., et al.
Publicado: (2021)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis
por: Wirtz, Theresa H., et al.
Publicado: (2020)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_88klorfd56nq3gspfmfhrg127v